骨骼生长刺激器市场规模（按产品、应用、最终用户、地区、范围和预测）

骨骼生长刺激剂的市场规模及预测

骨骼生长刺激器市场规模预计在 2023 年价值 13.6 亿美元，到 2031 年将达到 21.7 亿美元，2024 年至 2031 年的复合年增长率为 5.99%。骨骼生长刺激器是一种有助于骨骼修復和生长的医疗设备。它产生低水平电磁场和声波来刺激骨细胞，促进骨骼的生长和修復。此技术广泛应用于骨科医学，帮助骨折癒合，特别是癒合缓慢的骨折和不癒合的骨折，即骨骼无法正常癒合。骨骼生长刺激器也用于脊椎融合手术以加速癒合过程，并用于治疗骨质疏鬆症和骨关节炎以强化骨骼和缓解症状。

此外，骨骼生长刺激剂在加速骨折和疾病患者的癒合和改善预后方面发挥重要作用。

骨骼生长刺激器的全球市场动态

影响骨骼生长刺激器市场的关键市场动态

主要市场驱动因子

骨骼相关疾病的发生率不断上升：

骨质疏鬆症、骨折和其他骨骼相关疾病的发生率不断上升是骨骼生长刺激剂产业发展的主要推动因素。预计全球人口老化将推动市场成长，对改善骨癒合和再生的有效治疗的需求也将推动市场成长。

骨骼生长刺激器的技术进步：

骨骼生长刺激器的技术进步，包括便携式、非侵入性选择，使得治疗更容易获得且更有效。这些技术创新改善了患者的治疗效果和便利性，吸引了更多的使用者并促进了市场发展。

越来越人选择非手术治疗方案：

越来越多的患者和医疗保健提供者倾向于非手术治疗，因为与手术治疗相比，非手术治疗风险更小、成本更低。骨骼生长刺激器提供了一种非侵入性替代方法，从而提高了其普及度和市场需求。

政府支持政策及报销情况：

政府努力改善医疗保健基础设施，并制定有利于骨骼生长刺激药物的报销规则，使得这些治疗更便宜、更容易获得。这种监管支持鼓励了骨骼生长刺激剂的使用，从而促进了市场成长。

主要问题

设备及治疗费用高：

骨骼生长刺激器的高成本（包括初始购买和持续使用）限制了市场扩张。这些高昂的成本限制了保险不足的患者和居住在低收入地区的患者获得治疗的机会，从而降低了市场渗透率。

认识与理解有限：

潜在消费者和某些医疗保健提供者并不知道骨骼生长刺激剂的益处和用途。这种数位落差导致采用率低并限制了市场扩张，因为人们不会寻求或推荐这些治疗方案。

竞争性替代疗法：

药物、手术技术和其他非侵入性治疗与骨骼生长刺激剂竞争。这些替代疗法的可用性影响了患者和提供者的偏好，并限制了骨骼生长刺激剂的使用。

主要趋势：

智慧科技整合：

骨骼生长刺激器市场正在转向使用物联网和人工智慧等智慧技术来改善设备功能和患者监测。这些技术提供个人化的治疗方案和即时数据跟踪，以改善患者的治疗效果和参与度。

穿戴式和可携式装置的兴起：

开发可穿戴、可携式骨骼生长刺激器的趋势日益增长。这些设备可以在您舒适的家中使用，同时保持治疗效果，从而吸引广大寻求非侵入性、灵活治疗方案的患者。

注重研究与发展：

不断增加的研发投入正在加速开发更有效率、更有效的骨骼生长刺激剂。这一趋势正在带来联合疗法和新刺激技术等突破，推动产业发展并提供更好的治疗选择。

对非侵入性治疗的需求不断增加：

随着患者和医疗保健专业人员寻求侵入性较小、风险较低的治疗方法，对非侵入性骨骼生长刺激器的需求日益增加。这一趋势反映了医疗保健领域向微创治疗的更广泛转变，骨骼生长刺激器成为骨骼癒合和再生的最佳选择。

目录

第 1 章全球骨骼生长刺激器市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 骨骼生长刺激剂的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第 5 章。

• 概述
• 骨骼生长刺激装置
• 骨形态发生蛋白
• 富含血小板的血浆

第六章 全球骨骼生长刺激剂市场（按应用）

• 概述
• 脊椎融合手术
• 骨折延迟癒合与不癒合
• 口腔颚面外科
• 其他

第 7 章 骨骼生长刺激剂全球市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章全球骨骼生长刺激剂市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第九章 公司简介

• Arthrex, Inc.
• Essex Woodlands Healthcare Partners（Bioventus LLC）
• Colfax Corporation（DJO Global, Inc）
• Isto Biologics
• Johnson & Johnson（Depuy Synthes）
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings, Inc.

第 10 章附录

• 相关研究

Bone Growth Stimulator Market Size And Forecast

Bone Growth Stimulator Market size was valued at USD 1.36 Billion in 2023 and is projected to reach USD 2.17 Billion by 2031, growing at a CAGR of 5.99% from 2024 to 2031. A bone growth stimulator is a medical device that helps bones mend and grow. It works by generating low-level electromagnetic fields or acoustic waves that stimulate bone cells, causing them to grow and mend. This technology is widely utilized in orthopedic medicine to aid in the healing of fractures, particularly slow-healing or non-union fractures, in which bones fail to mend properly. Bone growth stimulators are also used in spinal fusion procedures to speed up the healing process, as well as in the treatment of osteoporosis and osteoarthritis to strengthen bones and relieve symptoms.

Furthermore, bone growth stimulators serve an important role in expediting healing and improving outcomes for patients suffering from bone fractures or diseases.

Global Bone Growth Stimulator Market Dynamics

The key market dynamics that are shaping the bone growth stimulator market include:

Key Market Drivers

Increasing Prevalence of Bone-Related Disorders:

The increasing prevalence of osteoporosis, fractures, and other bone-related disorders is a major driver of the bone growth stimulator industry. As the world's population ages, the demand for effective treatments to improve bone healing and regeneration rises is expected to drive market growth.

Technological Advancements in Bone Growth Stimulators:

Technological advancements in bone growth stimulators, such as portable and non-invasive choices, have made treatment more accessible and effective. These innovations improve patient outcomes and ease, attracting more users and driving market development.

Growing Preference for Non-Surgical Treatment Options:

Patients and healthcare providers are increasingly preferring non-surgical therapies since they are less risky and less expensive than surgical methods. Bone growth stimulators provide a non-invasive alternative, which boosts their popularity and market demand.

Supportive Government Policies and Reimbursement Scenario:

Government efforts to improve healthcare infrastructure, together with favorable reimbursement rules for bone growth stimulation medicines, have made these therapies more inexpensive and accessible. This regulatory support promotes the use of bone growth stimulators, which drives market growth.

Key Challenges:

High Cost of Devices and Treatment:

The high cost of bone growth stimulators, including initial purchase and continued usage, limits market expansion. This high cost restricts access for patients without adequate insurance coverage or those living in low-income areas, reducing market penetration.

Limited Awareness and Understanding:

Potential consumers and certain healthcare providers are unaware of the benefits and applications of bone growth stimulators. This information gap reduces the adoption rate since people may not seek out or recommend these treatment choices, limiting market expansion.

Competition from Alternative Treatment Options:

Pharmaceuticals, surgical techniques, and other non-invasive therapies compete with bone growth stimulators. The availability of these alternatives influences patient and provider preferences, which limits the use of bone growth stimulators.

Key Trends:

Integration of Smart Technologies:

The bone growth stimulator market is experiencing a shift towards the use of smart technologies like IoT and AI to improve device functionality and patient monitoring. These technologies offer personalized treatment regimens and real-time data tracking, which improves patient results and participation.

Expansion of Wearable and Portable Devices:

There is a growing trend in developing wearable and portable bone growth stimulators. These devices provide the comfort of home use while maintaining treatment efficacy, making them appealing to a broader patient demography looking for non-invasive and flexible treatment choices.

Focus on Research and Development:

Increased investment in R&D is accelerating the development of more efficient and effective bone growth stimulators. This trend is leading to breakthroughs such as combining therapies and novel stimulation techniques, which will advance the industry and provide better healing options.

Rising Demand for Non-Invasive Treatments:

As patients and healthcare professionals seek less intrusive and lower-risk treatment choices, the need for non-invasive bone growth stimulators is increasing. This trend reflects a broader change in healthcare towards minimally invasive therapies, with bone growth stimulators emerging as a top choice for bone healing and regeneration.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Bone Growth Stimulator Market Regional Analysis

Here is a more detailed regional analysis of the bone growth stimulator market:

North America:

According to Verified Market Research, North America is estimated to dominate the bone growth stimulator market during the forecast period. North America, particularly the United States, has a sophisticated healthcare system that places a significant focus on innovation and technological uptake. This environment promotes the development and early use of innovative medical devices, such as bone growth stimulators, which drives market expansion in the region.

The region has a high incidence of bone-related disorders such as osteoporosis and fractures, particularly among the elderly. This demographic trend raises the demand for effective bone healing therapies, making bone growth stimulators more popular.

Many top medical device companies and research institutions focused on the development of bone growth stimulators are based in North America. The region's market dominance is maintained by a strong concentration on R&D, backed up by large investment.

Furthermore, the United States, in particular, has advantageous healthcare payment rules that cover a wide range of treatments, including the usage of bone growth stimulators. These regulations make therapies more accessible to patients and stimulate the use of innovative medical equipment, which helps the industry grow in North America.

Asia Pacific:

Asia Pacific is experiencing a significant rise in the ageing population, particularly in Japan and China. This demographic transition increases the frequency of bone-related disorders such as osteoporosis and fractures, driving up demand for bone growth stimulators in the region

Many Asia Pacific countries are quickly expanding their healthcare infrastructure and boosting healthcare spending. This advancement increases access to innovative medical treatments and technology, such as bone growth stimulators, driving market growth.

Furthermore, economic expansion in the Asia Pacific region is resulting in greater healthcare investments from both governments and private enterprises. This financial assistance promotes the use of innovative medical equipment, such as bone growth stimulators, as part of larger initiatives to enhance healthcare results.

Europe:

Europe has a high rate of sports-related injuries and orthopedic surgeries due to active participation in sports and an ageing population. This increases the demand for effective rehabilitation and bone healing solutions, such as bone growth stimulators, to assure a speedy and complete recovery.

European countries have well-developed healthcare systems that provide complete coverage, including innovative medical devices. This makes bone growth stimulators more accessible to a wider spectrum of patients, boosting regional market growth.

Furthermore, in Europe, there is a rising preference for non-invasive treatment options over traditional surgical treatments due to their shorter recovery times and decreased risk of problems. This tendency encourages the use and market expansion of bone growth stimulators as a noninvasive therapeutic option.

Global Bone Growth Stimulator Market: Segmentation Analysis

The Bone Growth Stimulator Market is segmented based on Product, Application, End User and Geography.

Bone Growth Stimulator Market, By Product

• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins
• Platelet-rich Plasma

Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-rich Plasma. The bone growth stimulation devices segment is estimated to dominate the bone growth stimulator market due to a variety of causes, including the devices' wide range of applications in expediting fracture healing and promoting bone formation after surgery. Bone growth stimulation devices, which include both invasive and non-invasive technologies, are a diverse and effective alternative for patients looking to improve their bone health without undergoing additional procedures. Their ease of use, combined with the flexibility to be used in outpatient settings, contributes greatly to their appeal.

Bone Growth Stimulator Market, By Application

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries
• Other Applications

Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. The spinal fusion surgeries segment is estimated to dominate the bone growth stimulator market during the forecast period due to the rising incidence of spinal illnesses, such as degenerative disc degeneration and spinal stenosis, particularly among the elderly. Spinal fusion surgery is a typical treatment for these problems, which aims to relieve pain and restore spinal stability. Bone growth stimulators are essential for accelerating bone healing after surgery, ensuring successful fusion and recovery. Their efficiency in improving surgical outcomes, combined with the increasing number of spinal fusion procedures conducted worldwide, boosts demand and market share for this application segment.

Bone Growth Stimulator Market, By End User

• Hospitals and Ambulatory Surgical Centers
• Home Care Settings
• Academic and Research Institutes

Based on the End User, the bone growth stimulator market is divided into Hospitals & Ambulatory Surgical Centers, Home Care Settings, and Academic & Research Institutes. The hospitals and ambulatory surgical centers segment is estimated to dominate the market over the forecast period. The complex nature and severity of cases treated in these settings often require the use of modern medical equipment, such as bone growth stimulators, to ensure the best patient results. Hospitals and ambulatory surgical centres have the required infrastructure and qualified experts to deliver such treatments efficiently. Furthermore, these settings are more likely to be the first line of treatment for injuries and diseases that require bone development stimulation, such as fractures or operations.

Bone Growth Stimulator Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the bone growth stimulator market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate during the forecasted period owing to the region's advanced healthcare infrastructure, a high frequency of bone-related disorders, significant R&D investments, and favourable healthcare legislation, such as extensive reimbursement schemes. The United States, in particular, plays an important role in driving the market due to its high healthcare spending, emphasis on breakthrough medical technology, and big ageing population that demands bone-related treatments.

Key Players

• The "Bone Growth Stimulator Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zimmer Biomet, Stryker Corporation, Johnson & Johnson, Ossur hf., B. Braun Melsungen AG, DJO Global, Arthrogenix, IEX Medical, EMS Physiotherapy Equipment Ltd., SONOSTAT, Alvar, SPIRE Corp., Stimulation Technologies, DJO Surgical, Donjoy and EBI Medical Products.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In February 2024, Mainstay Medical announced a US$125 million equity financing transaction. This announcement shows a large investment in the bone growth stimulator field, which could indicate further market expansion and development.
• In February 2024, Orthofix received FDA and CE Mark Approval for New Bone Growth Stimulants. This highlights regulatory approvals for new bone growth stimulators, highlighting prospective advances in technology and therapy choices.
• In February 2024, SI-BONE, Inc., a corporation specializing in sacroiliac joint fusion with minimally invasive procedures, published financial results and guided 2024.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BONE GROWTH STIMULATOR MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL BONE GROWTH STIMULATOR MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL BONE GROWTH STIMULATOR MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Bone Growth Stimulation Devices
• 5.3 Bone Morphogenetic Proteins
• 5.4 Platelet-Rich Plasma

6 GLOBAL BONE GROWTH STIMULATOR MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Spinal Fusion Surgeries
• 6.3 Delayed Union & Nonunion Bone Fractures
• 6.4 Oral & Maxillofacial Surgeries
• 6.5 Others

7 GLOBAL BONE GROWTH STIMULATOR MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL BONE GROWTH STIMULATOR MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Arthrex, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Essex Woodlands Healthcare Partners (Bioventus LLC)
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Colfax Corporation (DJO Global, Inc)
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Isto Biologics
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Johnson & Johnson (Depuy Synthes)
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Medtronic Plc
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Orthofix Medical Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Stryker Corporation
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Terumo Corporation
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Zimmer Biomet Holdings, Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments

10 Appendix

• 10.1 Related Research